系统性硬化症中氨酸酶的治疗前景:系统性审查
Anika Pulumati1, Rachel Lin1, Scott A Elman1
1University of Miami Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miami, FL, USA.
Dermatology practical & conceptual
|August 9, 2024
概括
氨酸酶在治疗系统性硬化症相关的微静止病方面表现有前途,改善口腔口腔,副作用最小. 需要对更大规模的研究进行进一步的研究,以证实它在治疗硬性皮肤炎的有效性.
科学领域:
- 类风湿病学 类风湿病学
- 皮肤病学 皮肤病学
- 药理学 药理学 是一个学科.
背景情况:
- 系统性硬化症 (硬皮症) 是一种慢性自身免疫性疾病,会导致组织损伤和纤维化.
- 目前对系统性硬化症的治疗方法有限,这凸显了对新型治疗选择的需求.
- 氨酸酶已经成为系统性硬化症的潜在治疗方法.
研究的目的:
- 系统地审查hyaluronidase在全身性硬化症的治疗应用.
- 评估hyaluronidase在治疗系统性硬化症并发症方面的疗效和安全性.
主要方法:
- 在PubMed和Embase上进行了全面的文献搜索.
- 包括的研究发表于2013年至2023年期间,重点是人类受试者或体外人类细胞系.
- 文章的选择是基于系统性硬化症的治疗用途,不包括其他疾病.
主要成果:
- 十篇文章符合审查的纳入标准.
- 皮内氨酸酶通过增加口腔口径而改善了全身性硬化症中的微口腔,副作用很少.
- 在所有研究中都观察到一致的改善,尽管治疗方案各不相同,往往需要多次注射.
结论:
- 案例研究表明, hialuronidase 在全身性硬化症相关的微静止症中有效.
- 为了进一步验证,需要更大的样本大小,标准化的协议和定义的结果.
- hialuronidase 代表了一种有前途的治疗途径,用于管理多发性硬皮症的并发症.
更多相关视频
06:54Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion
Published on: June 15, 2019
6.0K
09:36Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
2.2K
相关概念视频
01:24Nephrotic Syndrome I : Introduction
1.2K
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
1.2K
01:26Nephrotic Syndrome II : Assessment and Medical Management
409
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
409